These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6383483)

  • 41. Involvement of endogenous epinephrine in histamine-induced hyperinsulinemia and hypoglycemia in rats treated with islet-activating protein.
    Yajima M; Kurokawa S; Takahashi I
    Biochem Pharmacol; 1981 Dec; 30(24):3306-9. PubMed ID: 7034735
    [No Abstract]   [Full Text] [Related]  

  • 42. Islet-activating protein (IAP) reduces bethanechol-stimulated release of pancreatic polypeptide in the dog.
    Hanafusa T; Toyoshima H; Nonaka K; Tarui S
    Endocrinol Jpn; 1982 Jun; 29(3):357-61. PubMed ID: 6756897
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Biological activities of crystalline pertussigen from Bordetella pertussis.
    Munoz JJ; Arai H; Bergman RK; Sadowski PL
    Infect Immun; 1981 Sep; 33(3):820-6. PubMed ID: 6269999
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glycerol-releasing activity of histamine-sensitizing factor of Bordetella pertussis for rat adipocytes in vitro.
    Endoh M; Nakase Y
    Microbiol Immunol; 1982; 26(8):689-703. PubMed ID: 6294484
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Enhanced peripheral glucose utilization and suppressed hepatic glycogen synthesis in KK mice treated with islet-activating protein (IAP).
    Okamoto T; Yajima M
    J Pharmacobiodyn; 1982 Mar; 5(3):148-54. PubMed ID: 7047714
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pertussis toxin potentiates anesthesia-induced renin secretion.
    Pedraza-Chaverrí J; Ibarra-Rubio ME; Alatorre-González MC; Peña JC; García-Sáinz JA
    Eur J Pharmacol; 1985 May; 112(1):115-7. PubMed ID: 3894036
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adjuvant for IgE antibody and islet-activating protein in Bordetella pertussis.
    Mizushima Y; Mori M; Ogita T; Nakamura T
    Int Arch Allergy Appl Immunol; 1979; 58(4):426-9. PubMed ID: 220196
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of dexamethasone and indomethacin on the vascular beta 2-adrenolytic action of pertussis toxin in rats; a prostaglandin-mediated phenomenon.
    De Wildt DJ; van der Beek EM; De Jong Y; Nijkamp FP; Kreeftenberg JG
    Eur J Pharmacol; 1985 Jan; 108(2):113-9. PubMed ID: 2858396
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improvement of diabetic symptoms of hereditary diabetic (KK) mice by a single injection with islet-activating protein (IAP).
    Okamoto T; Itoh A; Yajima M; Ui M
    J Pharmacobiodyn; 1980 Sep; 3(9):470-7. PubMed ID: 6257880
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of islet-activating protein (IAP) on blood glucose and plasma insulin in healthy volunteers (phase 1 studies).
    Toyota T; Kai Y; Kakizaki M; Sakai A; Goto Y; Yajima M; Ui M
    Tohoku J Exp Med; 1980 Feb; 130(2):105-16. PubMed ID: 6247781
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inflammatory toxin from Mycoplasma bovis: isolation and characterization.
    Geary SJ; Tourtellotte ME; Cameron JA
    Science; 1981 May; 212(4498):1032-3. PubMed ID: 7233196
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Production of lymphocytosis by polysaccharide polysulphates (heparinoids).
    Sasaki S
    Nature; 1967 Jun; 214(5092):1041-2. PubMed ID: 4168056
    [No Abstract]   [Full Text] [Related]  

  • 53. DFT and docking studies of rhodostreptomycins A and B and their interactions with solvated/nonsolvated Mg²⁺ and Ca²⁺ ions.
    Jardínez C; Nicolás-Vázquez I; Cruz-Borbolla J; González-Ramírez CA; Cepeda M; Correa-Basurto J; Pandiyan T; Miranda R
    J Mol Model; 2013 Nov; 19(11):4823-36. PubMed ID: 24026575
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reversal of the CD4(+)/CD8(+) T-cell ratio in lymph node cells upon in vitro mitogenic stimulation by highly purified, water-soluble S3-S4 dimer of pertussis toxin.
    Latif R; Kerlero de Rosbo N; Amarant T; Rappuoli R; Sappler G; Ben-Nun A
    Infect Immun; 2001 May; 69(5):3073-81. PubMed ID: 11292726
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human antibody response to the B oligomer of pertussis toxin.
    Lynn F; Burnette WN; Siber GR; Arciniega JL
    Clin Diagn Lab Immunol; 1994 Nov; 1(6):626-32. PubMed ID: 8556512
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of pertussis toxin analogs containing mutations in B-oligomer subunits.
    Loosmore S; Zealey G; Cockle S; Boux H; Chong P; Yacoob R; Klein M
    Infect Immun; 1993 Jun; 61(6):2316-24. PubMed ID: 8500874
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pertussis toxin activates platelets through an interaction with platelet glycoprotein Ib.
    Sindt KA; Hewlett EL; Redpath GT; Rappuoli R; Gray LS; Vandenberg SR
    Infect Immun; 1994 Aug; 62(8):3108-14. PubMed ID: 8039878
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mosquitocidal toxins of bacilli and their genetic manipulation for effective biological control of mosquitoes.
    Porter AG; Davidson EW; Liu JW
    Microbiol Rev; 1993 Dec; 57(4):838-61. PubMed ID: 7905597
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of Bordetella pertussis toxin pretreatment on the antiarrhythmic action of ischaemic preconditioning in anaesthetized rats.
    Piacentini L; Wainwright CL; Parratt JR
    Br J Pharmacol; 1995 Feb; 114(4):755-60. PubMed ID: 7773535
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immune response to the B oligomer of pertussis toxin.
    Arciniega JL; Burns DL; Garcia-Ortigoza E; Manclark CR
    Infect Immun; 1987 May; 55(5):1132-6. PubMed ID: 3570457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.